APA (7th ed.) Citation

McFarland, T. R., Tandar, C. E., Agarwal, N., & Swami, U. (2021). Emergence of polyclonal BRCA2 reversions following PARP inhibitor treatment. Cancer Treatment and Research Communications, 29(100480-), . https://doi.org/10.1016/j.ctarc.2021.100480

Chicago Style (17th ed.) Citation

McFarland, Taylor Ryan, Clara Elizabeth Tandar, Neeraj Agarwal, and Umang Swami. "Emergence of Polyclonal BRCA2 Reversions Following PARP Inhibitor Treatment." Cancer Treatment and Research Communications 29, no. 100480- (2021). https://doi.org/10.1016/j.ctarc.2021.100480.

MLA (9th ed.) Citation

McFarland, Taylor Ryan, et al. "Emergence of Polyclonal BRCA2 Reversions Following PARP Inhibitor Treatment." Cancer Treatment and Research Communications, vol. 29, no. 100480-, 2021, https://doi.org/10.1016/j.ctarc.2021.100480.